The scope of this work is to provide EPA with assay platforms that: (1) utilize rudimentary �organoids� and microscale tissues built from human pluripotent stem cell (iPSC) lines; (2) build microflui…
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Environmental Protection Agency is seeking assay platforms designed to advance toxicity testing through the use of human pluripotent stem cell lines. The primary objective is the development of rudimentary organoids and microscale tissues, integrated into microfluidic tissue chips. These chips must support both single and multi-organ configurations to facilitate long-term culture and sophisticated biological modeling. The scope of work requires the execution of in vitro toxicity studies using these novel platforms. These studies must be capable of producing measurable outcomes regarding metabolic capacity, biophysical mechanics, and cellular dynamics. This initiative aims to enhance the agency's ability to assess chemical toxicity using high-fidelity, human-based synthetic tissue models.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Environmental Protection Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
